Use of Xpert® MRSA PCR point-of-care testing beyond the laboratory

Journal of Hospital Infection

Volumn 87, Issue 2, 2014, Pages 119-121

  Parcell, B J ^a   Phillips, G ^a  

^a NHS TAYSIDE   (United Kingdom)

Author keywords

Meticillin resistant Staphylococcus aureus; Point of care testing; Polymerase chain reaction

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CONTROLLED STUDY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METICILLIN RESISTANT STAPHYLOCOCCUS AUREUS POLYMERASE CHAIN REACTION ASSAY; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TURNAROUND TIME; COMPARATIVE STUDY; EVALUATION STUDY; HOSPITAL INFORMATION SYSTEM; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MOLECULAR DIAGNOSIS; PROCEDURES; STAPHYLOCOCCAL INFECTIONS;

HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR DIAGNOSTIC TECHNIQUES; POINT-OF-CARE SYSTEMS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS;

EID: 84901671161     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2014.04.002     Document Type: Article

References (10)

1. Health Protection Scotland, National Services Scotland, NHS Scotland MRSA Screening Pathfinder Programme Final Report Volume 1: An investigation of the clinical effectiveness of MRSA screening. Health Protection Scotland; 2011.
2. Marlowe E.M., Bankowski M.J. Conventional and molecular methods for the detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2011, 49:53-56.
3. Guleri A., Kehoe A., Hartley J., et al. The cost and benefits of hospital MRSA screening. Br J Healthcare Manage 2011, 17:64-71.
4. Rossney A.S., Herra C.M., Brennan G.I., Morgan P.M., O'Connell B. Evaluation of the Xpert methicillin-resistant Staphylococcus aureus (MRSA) assay using the GeneXpert real-time PCR platform for rapid detection of MRSA from screening specimens. J Clin Microbiol 2008, 10:3285-3290.
5. Moore C. Point-of-care tests for infection control: should rapid testing be in the laboratory or at the front line?. J Hosp Infect 2013, 85:1-7.
6. Brenwald N.P., Baker N., Oppenheim B. Feasibility study of a real-time PCR test for meticillin-resistant Staphylococcus aureus in a point of care setting. J Hosp Infect 2010, 74:245-249.
7. Wolk D.M., Picton E., Johnson D., et al. Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. J Clin Microbiol 2009, 47:758-764.
8. Ganesan A., Crawford K., Mende K., et al. Evaluation for a novel methicillin resistance (mecc) homologue in methicillin-resistant Staphylococcus aureus isolates obtained from injured military personnel. J Clin Microbiol 2013, 51:3073-3075.
9. Stenehjem E., Rimland D., Crispell E.K., Stafford C., Gaynes R., Satola S.W. Cepheid Xpert MRSA cycle threshold in discordant colonization results and as a quantitative measure of nasal colonization burden. J Clin Microbiol 2012, 50:2079-2081.
10. Wolk D.M., Marx J.L., Dominguez L., Driscoll D., Schifman R.B. Comparison of MRSA Select agar, CHROMagar methicillin-resistant Staphylococcus aureus (MRSA) medium, and Xpert MRSA PCR for detection of MRSA in nares: diagnostic accuracy for surveillance samples with various bacterial densities. J Clin Microbiol 2009, 47:3933-3936.